Top Markets
Coin of the day
Eastgate Biotech Corp. Eastgate Biotech Corp.

Eastgate Biotech Corp.

ETBI
Rang in Aktien #34129
EastGate Biotech Corp. is a pharmaceutical company specializing in the... EastGate Biotech Corp. is a pharmaceutical company specializing in the production and distribution of nutraceuticals. These products are rooted in natural therapies and designed for natural absorption within the body. The firm employs cutting-edge nanotechnologies to provide healthier options compared to conventional pharmaceuticals, which often lead to detrimental side effects and unforeseen issues for individuals seeking to achieve and maintain good health. Among its diverse product line are E-Drops NANO, Essential D, GluCora, VCleanzz, Cleanezze, and Warts X. EastGate Biotech's development process involves integrating product components into various nano-sized delivery systems. These systems include oil droplets (nanoemulsions), polymeric particles (nanoparticles), and complex combinations of polymers, lipids, and surfactants (such as hybrid nanoparticles, nanocapsules, and mixed micelles). The company has operational bases in prominent cities including New York, London SF, Cockfosters BP, Los Angeles, Chicago, and Las Vegas.
Aktienkurs
$0.003
Zuletzt synchronisiert: 2026-08-13
Marktkapitalisierung
$6.17M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
-25.00%
Land
CA
Handel Eastgate Biotech Corp. (ETBI)

Kategorie

Kursverlauf für Eastgate Biotech Corp. (ETBI)
Höchster Schlusskurs: $0.00 am 2026-08-01

Niedrigster Schlusskurs: $0.44 am 2014-03-01
Kursverlauf der Aktie von Eastgate Biotech Corp. von 2014 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 0.00%
2025 17.90%
2024 -33.91%
2023 28.33%
2022 13.92%
2021 -20.04%
2020 -51.88%
2019 37.53%
2018 419.52%
2017 -96.92%
2016 76.31%
2015 -57.27%
2014 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$58.56 61.10%
US
$49.19 71.73%
SE
$185.04 40.51%
FR
$62.27 4.40%
IT
$114.37 59.39%
US